Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: VENXXIVA — Supplemental Application (Cycle Pharmaceuticals Ltd.)

View source ↗

Summary

The FDA approved a supplemental application for VENXXIVA (tiopronin) submitted by Cycle Pharmaceuticals Ltd. under ANDA216990. The action authorizes the changes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VENXXIVA (tiopronin)

Snippet

SUPPL AP for VENXXIVA (TIOPRONIN)